ClinConnect ClinConnect Logo
Search / Trial NCT06664944

Technology Exposure and Child Health: Wellness Impact and Social Effects: an Observational Product Registry Study

Launched by AURA · Oct 28, 2024

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Digital Health Digital Mental Health Technology Impacts On Mental Health Digital Natives Digital Parenthood Child Online Safety Digital Wellness Child Online Well Being

ClinConnect Summary

This clinical trial is looking at how kids’ use of mobile devices, like smartphones and tablets, affects their mental and physical health. The study focuses on children aged 8 to 17 and aims to see how time spent on social media and playing online games relates to their mood, stress levels, sleep quality, and physical activity. By comparing what kids say in surveys about their feelings and habits with their mobile device usage, researchers hope to gather valuable information about the impact of technology on child wellness.

To participate, children need to have their own mobile device with the Aura app installed, and both the child and a parent or guardian must agree to take part. During the three-month study, participants will answer monthly surveys and daily questions about their mood, stress, sleep, and physical activity. It's important to note that each child must use a dedicated device—meaning no sharing with siblings—so that the study can accurately track their data. This study is completely virtual, making it easy for families to join from home.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Child participants are male, female, non-binary persons, ages 8-17, inclusive
  • 2. Parent/Authorized Legal Guardian willing to provide informed consent; child willing to provide assent
  • 3. Both Parent/Authorized Legal Guardian and child own a mobile device that already has the Aura app or is able to install and run the Aura app, and the appropriate parental control features.
  • 4. Parent/Authorized Legal Guardian and child are willing for child to use a dedicated device for the duration of the study (ie., child cannot share device with a sibling or other family member).
  • 5. Multiple children from the same family are eligible to participate, provided that each enrolled child uses a dedicated device AND is able to complete outcome assessments independently, AND that parent/authorized legal guardian is able to complete assessments for each enrolled child.
  • 6. Both Parent/Authorized Legal Guardian and child willing to share data collected as part of the Aura app and related device applications
  • 7. Consented Parent/Authorized Legal Guardian and child maintain active Aura accounts throughout their study participation
  • 8. Consented Parent/Authorized Legal Guardian and child are able to follow written and verbal instructions (English) as assessed by the PI and/or study coordinator
  • 9. Consented Parent/Authorized Legal Guardian and child are to comply with all testing and study requirements

About Aura

Aura is a leading clinical trial sponsor dedicated to advancing innovative healthcare solutions through rigorous research and development. With a focus on enhancing patient outcomes, Aura collaborates with a network of healthcare professionals and institutions to design and execute clinical trials that adhere to the highest standards of scientific integrity and regulatory compliance. Our commitment to transparency, patient safety, and ethical practices ensures that we contribute meaningfully to the development of groundbreaking therapies across various therapeutic areas. By leveraging cutting-edge technologies and methodologies, Aura aims to accelerate the drug development process and bring transformative treatments to market efficiently.

Locations

Boston, Massachusetts, United States

Patients applied

0 patients applied

Trial Officials

Scott Kollins, Doctorate in Psychology

Principal Investigator

Aura

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported